HCI Strategic Overview on Medicines Resilience

A ten-point overview of Europe’s medicines resilience challenge and the need for a shared, evidence-based approach to inventory reserves.

Why this Overview

Europe is advancing its medicines resilience policies, but a common model for designing inventory reserves is still missing. This overview sets out the decisions needed to turn policy ambition into an effective, affordable and patient-centred reserve architecture.

What it contains

The overview brings together ten strategic perspectives on medicines security, from emerging supply risks and Europe’s policy response to reserve design, investment priorities and patient outcomes. It explores a layered approach to reserves and identifies seven key questions to guide a common European framework.

Who it is for

This publication is intended for policymakers, manufacturers, distributors, healthcare providers, patient organisations, researchers and others involved in strengthening medicines availability and continuity of supply.

Do you have comments that you would like to share with us? Send us your views at info@healthcarechaininstitute.org.